nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproheptadine—HTR1A—stomach cancer	0.619	1	CbGaD
Cyproheptadine—CHRM3—muscle of abdomen—stomach cancer	0.0117	0.182	CbGeAlD
Cyproheptadine—HTR2A—myenteric nerve plexus—stomach cancer	0.00833	0.129	CbGeAlD
Cyproheptadine—HTR2A—vagus nerve—stomach cancer	0.00556	0.0859	CbGeAlD
Cyproheptadine—HTR2A—vein—stomach cancer	0.00537	0.083	CbGeAlD
Cyproheptadine—UGT1A3—digestive system—stomach cancer	0.00373	0.0577	CbGeAlD
Cyproheptadine—UGT1A3—endocrine gland—stomach cancer	0.00308	0.0477	CbGeAlD
Cyproheptadine—UGT1A3—liver—stomach cancer	0.00278	0.043	CbGeAlD
Cyproheptadine—HTR2A—blood vessel—stomach cancer	0.0017	0.0263	CbGeAlD
Cyproheptadine—HTR1A—hematopoietic system—stomach cancer	0.00152	0.0235	CbGeAlD
Cyproheptadine—HTR2B—smooth muscle tissue—stomach cancer	0.0015	0.0231	CbGeAlD
Cyproheptadine—CHRM3—smooth muscle tissue—stomach cancer	0.00135	0.0208	CbGeAlD
Cyproheptadine—Mianserin—HRH4—stomach cancer	0.00123	0.204	CrCbGaD
Cyproheptadine—HTR2B—digestive system—stomach cancer	0.00118	0.0183	CbGeAlD
Cyproheptadine—HRH1—hematopoietic system—stomach cancer	0.00109	0.0168	CbGeAlD
Cyproheptadine—CHRM2—endocrine gland—stomach cancer	0.00108	0.0167	CbGeAlD
Cyproheptadine—CHRM3—digestive system—stomach cancer	0.00106	0.0164	CbGeAlD
Cyproheptadine—HRH1—epithelium—stomach cancer	0.000993	0.0154	CbGeAlD
Cyproheptadine—CHRM1—endocrine gland—stomach cancer	0.000982	0.0152	CbGeAlD
Cyproheptadine—Loxapine—HRH4—stomach cancer	0.000976	0.162	CrCbGaD
Cyproheptadine—HRH1—smooth muscle tissue—stomach cancer	0.000957	0.0148	CbGeAlD
Cyproheptadine—HTR2A—hematopoietic system—stomach cancer	0.000907	0.014	CbGeAlD
Cyproheptadine—CHRM3—endocrine gland—stomach cancer	0.000878	0.0136	CbGeAlD
Cyproheptadine—HTR1A—endocrine gland—stomach cancer	0.000875	0.0135	CbGeAlD
Cyproheptadine—SLC6A2—endocrine gland—stomach cancer	0.000867	0.0134	CbGeAlD
Cyproheptadine—HTR2A—epithelium—stomach cancer	0.000829	0.0128	CbGeAlD
Cyproheptadine—Clozapine—HRH4—stomach cancer	0.000819	0.136	CrCbGaD
Cyproheptadine—HTR2A—smooth muscle tissue—stomach cancer	0.000799	0.0124	CbGeAlD
Cyproheptadine—DRD2—endocrine gland—stomach cancer	0.00079	0.0122	CbGeAlD
Cyproheptadine—Amitriptyline—HRH4—stomach cancer	0.000762	0.126	CrCbGaD
Cyproheptadine—HRH1—digestive system—stomach cancer	0.000755	0.0117	CbGeAlD
Cyproheptadine—HTR2B—lymph node—stomach cancer	0.000675	0.0104	CbGeAlD
Cyproheptadine—HTR2A—digestive system—stomach cancer	0.000631	0.00976	CbGeAlD
Cyproheptadine—HRH1—endocrine gland—stomach cancer	0.000624	0.00965	CbGeAlD
Cyproheptadine—SLC6A2—lymph node—stomach cancer	0.0006	0.00927	CbGeAlD
Cyproheptadine—Syncope—Irinotecan—stomach cancer	0.000572	0.00359	CcSEcCtD
Cyproheptadine—Leukopenia—Irinotecan—stomach cancer	0.000571	0.00358	CcSEcCtD
Cyproheptadine—Photosensitivity—Epirubicin—stomach cancer	0.000562	0.00353	CcSEcCtD
Cyproheptadine—Loss of consciousness—Irinotecan—stomach cancer	0.00056	0.00352	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Capecitabine—stomach cancer	0.000559	0.00351	CcSEcCtD
Cyproheptadine—Weight increased—Capecitabine—stomach cancer	0.000557	0.0035	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Docetaxel—stomach cancer	0.000553	0.00347	CcSEcCtD
Cyproheptadine—Jaundice—Docetaxel—stomach cancer	0.00055	0.00345	CcSEcCtD
Cyproheptadine—Hepatic failure—Epirubicin—stomach cancer	0.000549	0.00345	CcSEcCtD
Cyproheptadine—Leukopenia—Fluorouracil—stomach cancer	0.000547	0.00343	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Capecitabine—stomach cancer	0.000535	0.00336	CcSEcCtD
Cyproheptadine—Jaundice—Capecitabine—stomach cancer	0.000532	0.00334	CcSEcCtD
Cyproheptadine—Convulsion—Fluorouracil—stomach cancer	0.000529	0.00332	CcSEcCtD
Cyproheptadine—Agranulocytosis—Docetaxel—stomach cancer	0.000526	0.0033	CcSEcCtD
Cyproheptadine—Increased appetite—Epirubicin—stomach cancer	0.000525	0.0033	CcSEcCtD
Cyproheptadine—Confusional state—Irinotecan—stomach cancer	0.000525	0.00329	CcSEcCtD
Cyproheptadine—HTR2A—endocrine gland—stomach cancer	0.000521	0.00806	CbGeAlD
Cyproheptadine—Oedema—Irinotecan—stomach cancer	0.00052	0.00327	CcSEcCtD
Cyproheptadine—Photosensitivity—Doxorubicin—stomach cancer	0.00052	0.00326	CcSEcCtD
Cyproheptadine—Shock—Irinotecan—stomach cancer	0.000512	0.00321	CcSEcCtD
Cyproheptadine—Agranulocytosis—Capecitabine—stomach cancer	0.00051	0.0032	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Irinotecan—stomach cancer	0.00051	0.0032	CcSEcCtD
Cyproheptadine—Hepatic failure—Doxorubicin—stomach cancer	0.000508	0.00319	CcSEcCtD
Cyproheptadine—Hepatitis—Docetaxel—stomach cancer	0.000506	0.00318	CcSEcCtD
Cyproheptadine—Irritability—Methotrexate—stomach cancer	0.000503	0.00316	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Irinotecan—stomach cancer	0.000503	0.00316	CcSEcCtD
Cyproheptadine—Confusional state—Fluorouracil—stomach cancer	0.000503	0.00315	CcSEcCtD
Cyproheptadine—Oedema—Fluorouracil—stomach cancer	0.000498	0.00313	CcSEcCtD
Cyproheptadine—Anorexia—Irinotecan—stomach cancer	0.000496	0.00311	CcSEcCtD
Cyproheptadine—Diplopia—Epirubicin—stomach cancer	0.000494	0.0031	CcSEcCtD
Cyproheptadine—Hepatitis—Capecitabine—stomach cancer	0.00049	0.00308	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Fluorouracil—stomach cancer	0.000488	0.00306	CcSEcCtD
Cyproheptadine—Tachycardia—Fluorouracil—stomach cancer	0.000486	0.00305	CcSEcCtD
Cyproheptadine—Hypotension—Irinotecan—stomach cancer	0.000486	0.00305	CcSEcCtD
Cyproheptadine—Increased appetite—Doxorubicin—stomach cancer	0.000486	0.00305	CcSEcCtD
Cyproheptadine—Anorexia—Fluorouracil—stomach cancer	0.000475	0.00298	CcSEcCtD
Cyproheptadine—Insomnia—Irinotecan—stomach cancer	0.000471	0.00295	CcSEcCtD
Cyproheptadine—HTR2A—liver—stomach cancer	0.00047	0.00727	CbGeAlD
Cyproheptadine—Paraesthesia—Irinotecan—stomach cancer	0.000467	0.00293	CcSEcCtD
Cyproheptadine—Hypotension—Fluorouracil—stomach cancer	0.000466	0.00292	CcSEcCtD
Cyproheptadine—Somnolence—Irinotecan—stomach cancer	0.000463	0.0029	CcSEcCtD
Cyproheptadine—Dyspepsia—Irinotecan—stomach cancer	0.000458	0.00287	CcSEcCtD
Cyproheptadine—Tinnitus—Capecitabine—stomach cancer	0.000457	0.00287	CcSEcCtD
Cyproheptadine—Diplopia—Doxorubicin—stomach cancer	0.000457	0.00287	CcSEcCtD
Cyproheptadine—Chills—Docetaxel—stomach cancer	0.000454	0.00285	CcSEcCtD
Cyproheptadine—Decreased appetite—Irinotecan—stomach cancer	0.000452	0.00284	CcSEcCtD
Cyproheptadine—Insomnia—Fluorouracil—stomach cancer	0.000451	0.00283	CcSEcCtD
Cyproheptadine—Fatigue—Irinotecan—stomach cancer	0.000449	0.00282	CcSEcCtD
Cyproheptadine—Paraesthesia—Fluorouracil—stomach cancer	0.000448	0.00281	CcSEcCtD
Cyproheptadine—Constipation—Irinotecan—stomach cancer	0.000445	0.00279	CcSEcCtD
Cyproheptadine—Somnolence—Fluorouracil—stomach cancer	0.000443	0.00278	CcSEcCtD
Cyproheptadine—Chills—Capecitabine—stomach cancer	0.00044	0.00276	CcSEcCtD
Cyproheptadine—Dyspepsia—Fluorouracil—stomach cancer	0.000439	0.00275	CcSEcCtD
Cyproheptadine—Decreased appetite—Fluorouracil—stomach cancer	0.000433	0.00272	CcSEcCtD
Cyproheptadine—HRH1—lymph node—stomach cancer	0.000432	0.00667	CbGeAlD
Cyproheptadine—Feeling abnormal—Irinotecan—stomach cancer	0.000429	0.00269	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Methotrexate—stomach cancer	0.000416	0.00261	CcSEcCtD
Cyproheptadine—Feeling abnormal—Fluorouracil—stomach cancer	0.000411	0.00258	CcSEcCtD
Cyproheptadine—Drowsiness—Methotrexate—stomach cancer	0.000407	0.00255	CcSEcCtD
Cyproheptadine—Vision blurred—Capecitabine—stomach cancer	0.000402	0.00252	CcSEcCtD
Cyproheptadine—Tremor—Capecitabine—stomach cancer	0.0004	0.00251	CcSEcCtD
Cyproheptadine—Urticaria—Fluorouracil—stomach cancer	0.000396	0.00248	CcSEcCtD
Cyproheptadine—Syncope—Docetaxel—stomach cancer	0.000395	0.00248	CcSEcCtD
Cyproheptadine—Leukopenia—Docetaxel—stomach cancer	0.000395	0.00248	CcSEcCtD
Cyproheptadine—Pollakiuria—Epirubicin—stomach cancer	0.000394	0.00247	CcSEcCtD
Cyproheptadine—Palpitations—Docetaxel—stomach cancer	0.00039	0.00244	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Epirubicin—stomach cancer	0.000389	0.00244	CcSEcCtD
Cyproheptadine—Weight increased—Epirubicin—stomach cancer	0.000388	0.00244	CcSEcCtD
Cyproheptadine—Loss of consciousness—Docetaxel—stomach cancer	0.000387	0.00243	CcSEcCtD
Cyproheptadine—Vertigo—Capecitabine—stomach cancer	0.000383	0.00241	CcSEcCtD
Cyproheptadine—Syncope—Capecitabine—stomach cancer	0.000383	0.0024	CcSEcCtD
Cyproheptadine—Leukopenia—Capecitabine—stomach cancer	0.000382	0.0024	CcSEcCtD
Cyproheptadine—Convulsion—Docetaxel—stomach cancer	0.000382	0.0024	CcSEcCtD
Cyproheptadine—Drowsiness—Epirubicin—stomach cancer	0.00038	0.00239	CcSEcCtD
Cyproheptadine—Agranulocytosis—Methotrexate—stomach cancer	0.000379	0.00238	CcSEcCtD
Cyproheptadine—Palpitations—Capecitabine—stomach cancer	0.000377	0.00237	CcSEcCtD
Cyproheptadine—Loss of consciousness—Capecitabine—stomach cancer	0.000375	0.00235	CcSEcCtD
Cyproheptadine—Asthenia—Irinotecan—stomach cancer	0.000373	0.00234	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Epirubicin—stomach cancer	0.000373	0.00234	CcSEcCtD
Cyproheptadine—Jaundice—Epirubicin—stomach cancer	0.000371	0.00233	CcSEcCtD
Cyproheptadine—Hepatitis—Methotrexate—stomach cancer	0.000365	0.00229	CcSEcCtD
Cyproheptadine—Pollakiuria—Doxorubicin—stomach cancer	0.000365	0.00229	CcSEcCtD
Cyproheptadine—Confusional state—Docetaxel—stomach cancer	0.000363	0.00228	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Doxorubicin—stomach cancer	0.00036	0.00226	CcSEcCtD
Cyproheptadine—Oedema—Docetaxel—stomach cancer	0.00036	0.00226	CcSEcCtD
Cyproheptadine—Weight increased—Doxorubicin—stomach cancer	0.000359	0.00225	CcSEcCtD
Cyproheptadine—Diarrhoea—Irinotecan—stomach cancer	0.000356	0.00223	CcSEcCtD
Cyproheptadine—Agranulocytosis—Epirubicin—stomach cancer	0.000355	0.00223	CcSEcCtD
Cyproheptadine—Mianserin—HTR1A—stomach cancer	0.000355	0.0589	CrCbGaD
Cyproheptadine—Shock—Docetaxel—stomach cancer	0.000354	0.00222	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Docetaxel—stomach cancer	0.000352	0.00221	CcSEcCtD
Cyproheptadine—Drowsiness—Doxorubicin—stomach cancer	0.000352	0.00221	CcSEcCtD
Cyproheptadine—Confusional state—Capecitabine—stomach cancer	0.000351	0.0022	CcSEcCtD
Cyproheptadine—Tachycardia—Docetaxel—stomach cancer	0.000351	0.0022	CcSEcCtD
Cyproheptadine—Oedema—Capecitabine—stomach cancer	0.000348	0.00219	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Doxorubicin—stomach cancer	0.000345	0.00217	CcSEcCtD
Cyproheptadine—Dizziness—Irinotecan—stomach cancer	0.000344	0.00216	CcSEcCtD
Cyproheptadine—Jaundice—Doxorubicin—stomach cancer	0.000343	0.00215	CcSEcCtD
Cyproheptadine—Anorexia—Docetaxel—stomach cancer	0.000343	0.00215	CcSEcCtD
Cyproheptadine—Shock—Capecitabine—stomach cancer	0.000343	0.00215	CcSEcCtD
Cyproheptadine—Hepatitis—Epirubicin—stomach cancer	0.000342	0.00214	CcSEcCtD
Cyproheptadine—Diarrhoea—Fluorouracil—stomach cancer	0.000341	0.00214	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Capecitabine—stomach cancer	0.000341	0.00214	CcSEcCtD
Cyproheptadine—Tinnitus—Methotrexate—stomach cancer	0.00034	0.00214	CcSEcCtD
Cyproheptadine—Tachycardia—Capecitabine—stomach cancer	0.00034	0.00213	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Capecitabine—stomach cancer	0.000337	0.00211	CcSEcCtD
Cyproheptadine—Hypotension—Docetaxel—stomach cancer	0.000336	0.00211	CcSEcCtD
Cyproheptadine—Anorexia—Capecitabine—stomach cancer	0.000332	0.00208	CcSEcCtD
Cyproheptadine—Vomiting—Irinotecan—stomach cancer	0.000331	0.00208	CcSEcCtD
Cyproheptadine—Dizziness—Fluorouracil—stomach cancer	0.00033	0.00207	CcSEcCtD
Cyproheptadine—Agranulocytosis—Doxorubicin—stomach cancer	0.000328	0.00206	CcSEcCtD
Cyproheptadine—Rash—Irinotecan—stomach cancer	0.000328	0.00206	CcSEcCtD
Cyproheptadine—Dermatitis—Irinotecan—stomach cancer	0.000328	0.00206	CcSEcCtD
Cyproheptadine—Chills—Methotrexate—stomach cancer	0.000327	0.00205	CcSEcCtD
Cyproheptadine—Headache—Irinotecan—stomach cancer	0.000326	0.00205	CcSEcCtD
Cyproheptadine—Hypotension—Capecitabine—stomach cancer	0.000325	0.00204	CcSEcCtD
Cyproheptadine—Insomnia—Docetaxel—stomach cancer	0.000325	0.00204	CcSEcCtD
Cyproheptadine—Paraesthesia—Docetaxel—stomach cancer	0.000323	0.00203	CcSEcCtD
Cyproheptadine—Somnolence—Docetaxel—stomach cancer	0.00032	0.00201	CcSEcCtD
Cyproheptadine—Tinnitus—Epirubicin—stomach cancer	0.000318	0.002	CcSEcCtD
Cyproheptadine—Nortriptyline—HTR1A—stomach cancer	0.000317	0.0527	CrCbGaD
Cyproheptadine—Vomiting—Fluorouracil—stomach cancer	0.000317	0.00199	CcSEcCtD
Cyproheptadine—Dyspepsia—Docetaxel—stomach cancer	0.000317	0.00199	CcSEcCtD
Cyproheptadine—Hepatitis—Doxorubicin—stomach cancer	0.000316	0.00198	CcSEcCtD
Cyproheptadine—Loxapine—ADRB1—stomach cancer	0.000315	0.0523	CrCbGaD
Cyproheptadine—Insomnia—Capecitabine—stomach cancer	0.000315	0.00198	CcSEcCtD
Cyproheptadine—Rash—Fluorouracil—stomach cancer	0.000314	0.00197	CcSEcCtD
Cyproheptadine—Dermatitis—Fluorouracil—stomach cancer	0.000314	0.00197	CcSEcCtD
Cyproheptadine—Paraesthesia—Capecitabine—stomach cancer	0.000313	0.00196	CcSEcCtD
Cyproheptadine—Decreased appetite—Docetaxel—stomach cancer	0.000313	0.00196	CcSEcCtD
Cyproheptadine—Headache—Fluorouracil—stomach cancer	0.000312	0.00196	CcSEcCtD
Cyproheptadine—Fatigue—Docetaxel—stomach cancer	0.00031	0.00195	CcSEcCtD
Cyproheptadine—Nausea—Irinotecan—stomach cancer	0.000309	0.00194	CcSEcCtD
Cyproheptadine—Constipation—Docetaxel—stomach cancer	0.000308	0.00193	CcSEcCtD
Cyproheptadine—Dyspepsia—Capecitabine—stomach cancer	0.000307	0.00192	CcSEcCtD
Cyproheptadine—Chills—Epirubicin—stomach cancer	0.000306	0.00192	CcSEcCtD
Cyproheptadine—Decreased appetite—Capecitabine—stomach cancer	0.000303	0.0019	CcSEcCtD
Cyproheptadine—Fatigue—Capecitabine—stomach cancer	0.0003	0.00188	CcSEcCtD
Cyproheptadine—Vision blurred—Methotrexate—stomach cancer	0.000299	0.00188	CcSEcCtD
Cyproheptadine—Constipation—Capecitabine—stomach cancer	0.000298	0.00187	CcSEcCtD
Cyproheptadine—Feeling abnormal—Docetaxel—stomach cancer	0.000296	0.00186	CcSEcCtD
Cyproheptadine—Nausea—Fluorouracil—stomach cancer	0.000296	0.00186	CcSEcCtD
Cyproheptadine—Tinnitus—Doxorubicin—stomach cancer	0.000295	0.00185	CcSEcCtD
Cyproheptadine—Tension—Epirubicin—stomach cancer	0.000292	0.00183	CcSEcCtD
Cyproheptadine—Nervousness—Epirubicin—stomach cancer	0.000289	0.00181	CcSEcCtD
Cyproheptadine—Feeling abnormal—Capecitabine—stomach cancer	0.000287	0.0018	CcSEcCtD
Cyproheptadine—Vertigo—Methotrexate—stomach cancer	0.000285	0.00179	CcSEcCtD
Cyproheptadine—Leukopenia—Methotrexate—stomach cancer	0.000284	0.00178	CcSEcCtD
Cyproheptadine—Chills—Doxorubicin—stomach cancer	0.000284	0.00178	CcSEcCtD
Cyproheptadine—Loxapine—HTR1A—stomach cancer	0.000282	0.0468	CrCbGaD
Cyproheptadine—Vision blurred—Epirubicin—stomach cancer	0.00028	0.00176	CcSEcCtD
Cyproheptadine—Urticaria—Capecitabine—stomach cancer	0.000277	0.00174	CcSEcCtD
Cyproheptadine—Convulsion—Methotrexate—stomach cancer	0.000275	0.00173	CcSEcCtD
Cyproheptadine—Agitation—Epirubicin—stomach cancer	0.000273	0.00171	CcSEcCtD
Cyproheptadine—Clozapine—CYP2A6—stomach cancer	0.000272	0.0452	CrCbGaD
Cyproheptadine—Tension—Doxorubicin—stomach cancer	0.00027	0.00169	CcSEcCtD
Cyproheptadine—Nervousness—Doxorubicin—stomach cancer	0.000267	0.00168	CcSEcCtD
Cyproheptadine—Vertigo—Epirubicin—stomach cancer	0.000267	0.00168	CcSEcCtD
Cyproheptadine—Syncope—Epirubicin—stomach cancer	0.000267	0.00167	CcSEcCtD
Cyproheptadine—Leukopenia—Epirubicin—stomach cancer	0.000266	0.00167	CcSEcCtD
Cyproheptadine—Palpitations—Epirubicin—stomach cancer	0.000263	0.00165	CcSEcCtD
Cyproheptadine—Confusional state—Methotrexate—stomach cancer	0.000261	0.00164	CcSEcCtD
Cyproheptadine—Loss of consciousness—Epirubicin—stomach cancer	0.000261	0.00164	CcSEcCtD
Cyproheptadine—Vision blurred—Doxorubicin—stomach cancer	0.000259	0.00163	CcSEcCtD
Cyproheptadine—Asthenia—Docetaxel—stomach cancer	0.000258	0.00162	CcSEcCtD
Cyproheptadine—Convulsion—Epirubicin—stomach cancer	0.000258	0.00162	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Methotrexate—stomach cancer	0.000254	0.00159	CcSEcCtD
Cyproheptadine—Agitation—Doxorubicin—stomach cancer	0.000253	0.00159	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Methotrexate—stomach cancer	0.000251	0.00157	CcSEcCtD
Cyproheptadine—Asthenia—Capecitabine—stomach cancer	0.00025	0.00157	CcSEcCtD
Cyproheptadine—Vertigo—Doxorubicin—stomach cancer	0.000247	0.00155	CcSEcCtD
Cyproheptadine—Anorexia—Methotrexate—stomach cancer	0.000247	0.00155	CcSEcCtD
Cyproheptadine—Syncope—Doxorubicin—stomach cancer	0.000247	0.00155	CcSEcCtD
Cyproheptadine—Leukopenia—Doxorubicin—stomach cancer	0.000246	0.00155	CcSEcCtD
Cyproheptadine—Diarrhoea—Docetaxel—stomach cancer	0.000246	0.00154	CcSEcCtD
Cyproheptadine—Confusional state—Epirubicin—stomach cancer	0.000245	0.00154	CcSEcCtD
Cyproheptadine—Palpitations—Doxorubicin—stomach cancer	0.000243	0.00153	CcSEcCtD
Cyproheptadine—Oedema—Epirubicin—stomach cancer	0.000243	0.00152	CcSEcCtD
Cyproheptadine—Hypotension—Methotrexate—stomach cancer	0.000242	0.00152	CcSEcCtD
Cyproheptadine—Loss of consciousness—Doxorubicin—stomach cancer	0.000242	0.00152	CcSEcCtD
Cyproheptadine—Shock—Epirubicin—stomach cancer	0.000239	0.0015	CcSEcCtD
Cyproheptadine—Convulsion—Doxorubicin—stomach cancer	0.000238	0.0015	CcSEcCtD
Cyproheptadine—Diarrhoea—Capecitabine—stomach cancer	0.000238	0.0015	CcSEcCtD
Cyproheptadine—Dizziness—Docetaxel—stomach cancer	0.000238	0.00149	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Epirubicin—stomach cancer	0.000238	0.00149	CcSEcCtD
Cyproheptadine—Tachycardia—Epirubicin—stomach cancer	0.000237	0.00149	CcSEcCtD
Cyproheptadine—Clozapine—HTR1A—stomach cancer	0.000237	0.0393	CrCbGaD
Cyproheptadine—Hyperhidrosis—Epirubicin—stomach cancer	0.000235	0.00147	CcSEcCtD
Cyproheptadine—Insomnia—Methotrexate—stomach cancer	0.000235	0.00147	CcSEcCtD
Cyproheptadine—Paraesthesia—Methotrexate—stomach cancer	0.000233	0.00146	CcSEcCtD
Cyproheptadine—Anorexia—Epirubicin—stomach cancer	0.000231	0.00145	CcSEcCtD
Cyproheptadine—Somnolence—Methotrexate—stomach cancer	0.00023	0.00145	CcSEcCtD
Cyproheptadine—Dizziness—Capecitabine—stomach cancer	0.00023	0.00145	CcSEcCtD
Cyproheptadine—Vomiting—Docetaxel—stomach cancer	0.000229	0.00144	CcSEcCtD
Cyproheptadine—Dyspepsia—Methotrexate—stomach cancer	0.000228	0.00143	CcSEcCtD
Cyproheptadine—Rash—Docetaxel—stomach cancer	0.000227	0.00142	CcSEcCtD
Cyproheptadine—Hypotension—Epirubicin—stomach cancer	0.000227	0.00142	CcSEcCtD
Cyproheptadine—Dermatitis—Docetaxel—stomach cancer	0.000227	0.00142	CcSEcCtD
Cyproheptadine—Confusional state—Doxorubicin—stomach cancer	0.000226	0.00142	CcSEcCtD
Cyproheptadine—Decreased appetite—Methotrexate—stomach cancer	0.000225	0.00141	CcSEcCtD
Cyproheptadine—Headache—Docetaxel—stomach cancer	0.000225	0.00141	CcSEcCtD
Cyproheptadine—Oedema—Doxorubicin—stomach cancer	0.000225	0.00141	CcSEcCtD
Cyproheptadine—Fatigue—Methotrexate—stomach cancer	0.000224	0.0014	CcSEcCtD
Cyproheptadine—Vomiting—Capecitabine—stomach cancer	0.000221	0.00139	CcSEcCtD
Cyproheptadine—Shock—Doxorubicin—stomach cancer	0.000221	0.00139	CcSEcCtD
Cyproheptadine—Amitriptyline—HTR1A—stomach cancer	0.00022	0.0365	CrCbGaD
Cyproheptadine—Thrombocytopenia—Doxorubicin—stomach cancer	0.00022	0.00138	CcSEcCtD
Cyproheptadine—Rash—Capecitabine—stomach cancer	0.00022	0.00138	CcSEcCtD
Cyproheptadine—Insomnia—Epirubicin—stomach cancer	0.000219	0.00138	CcSEcCtD
Cyproheptadine—Dermatitis—Capecitabine—stomach cancer	0.000219	0.00138	CcSEcCtD
Cyproheptadine—Tachycardia—Doxorubicin—stomach cancer	0.000219	0.00138	CcSEcCtD
Cyproheptadine—Headache—Capecitabine—stomach cancer	0.000218	0.00137	CcSEcCtD
Cyproheptadine—Paraesthesia—Epirubicin—stomach cancer	0.000218	0.00137	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Doxorubicin—stomach cancer	0.000217	0.00136	CcSEcCtD
Cyproheptadine—Somnolence—Epirubicin—stomach cancer	0.000216	0.00135	CcSEcCtD
Cyproheptadine—Anorexia—Doxorubicin—stomach cancer	0.000214	0.00134	CcSEcCtD
Cyproheptadine—Nausea—Docetaxel—stomach cancer	0.000214	0.00134	CcSEcCtD
Cyproheptadine—Feeling abnormal—Methotrexate—stomach cancer	0.000214	0.00134	CcSEcCtD
Cyproheptadine—Dyspepsia—Epirubicin—stomach cancer	0.000214	0.00134	CcSEcCtD
Cyproheptadine—Decreased appetite—Epirubicin—stomach cancer	0.000211	0.00132	CcSEcCtD
Cyproheptadine—Hypotension—Doxorubicin—stomach cancer	0.00021	0.00132	CcSEcCtD
Cyproheptadine—Fatigue—Epirubicin—stomach cancer	0.000209	0.00131	CcSEcCtD
Cyproheptadine—Constipation—Epirubicin—stomach cancer	0.000207	0.0013	CcSEcCtD
Cyproheptadine—Nausea—Capecitabine—stomach cancer	0.000207	0.0013	CcSEcCtD
Cyproheptadine—Urticaria—Methotrexate—stomach cancer	0.000206	0.00129	CcSEcCtD
Cyproheptadine—Insomnia—Doxorubicin—stomach cancer	0.000203	0.00127	CcSEcCtD
Cyproheptadine—Paraesthesia—Doxorubicin—stomach cancer	0.000202	0.00127	CcSEcCtD
Cyproheptadine—Feeling abnormal—Epirubicin—stomach cancer	0.0002	0.00125	CcSEcCtD
Cyproheptadine—Somnolence—Doxorubicin—stomach cancer	0.0002	0.00125	CcSEcCtD
Cyproheptadine—Dyspepsia—Doxorubicin—stomach cancer	0.000198	0.00124	CcSEcCtD
Cyproheptadine—Decreased appetite—Doxorubicin—stomach cancer	0.000195	0.00122	CcSEcCtD
Cyproheptadine—Fatigue—Doxorubicin—stomach cancer	0.000194	0.00121	CcSEcCtD
Cyproheptadine—Urticaria—Epirubicin—stomach cancer	0.000193	0.00121	CcSEcCtD
Cyproheptadine—Constipation—Doxorubicin—stomach cancer	0.000192	0.0012	CcSEcCtD
Cyproheptadine—Asthenia—Methotrexate—stomach cancer	0.000186	0.00117	CcSEcCtD
Cyproheptadine—Feeling abnormal—Doxorubicin—stomach cancer	0.000185	0.00116	CcSEcCtD
Cyproheptadine—Urticaria—Doxorubicin—stomach cancer	0.000178	0.00112	CcSEcCtD
Cyproheptadine—Diarrhoea—Methotrexate—stomach cancer	0.000177	0.00111	CcSEcCtD
Cyproheptadine—Asthenia—Epirubicin—stomach cancer	0.000174	0.00109	CcSEcCtD
Cyproheptadine—Dizziness—Methotrexate—stomach cancer	0.000171	0.00108	CcSEcCtD
Cyproheptadine—Diarrhoea—Epirubicin—stomach cancer	0.000166	0.00104	CcSEcCtD
Cyproheptadine—Vomiting—Methotrexate—stomach cancer	0.000165	0.00103	CcSEcCtD
Cyproheptadine—Rash—Methotrexate—stomach cancer	0.000163	0.00103	CcSEcCtD
Cyproheptadine—Dermatitis—Methotrexate—stomach cancer	0.000163	0.00102	CcSEcCtD
Cyproheptadine—Headache—Methotrexate—stomach cancer	0.000162	0.00102	CcSEcCtD
Cyproheptadine—Asthenia—Doxorubicin—stomach cancer	0.000161	0.00101	CcSEcCtD
Cyproheptadine—Dizziness—Epirubicin—stomach cancer	0.00016	0.00101	CcSEcCtD
Cyproheptadine—Vomiting—Epirubicin—stomach cancer	0.000154	0.000968	CcSEcCtD
Cyproheptadine—Nausea—Methotrexate—stomach cancer	0.000154	0.000966	CcSEcCtD
Cyproheptadine—Diarrhoea—Doxorubicin—stomach cancer	0.000154	0.000964	CcSEcCtD
Cyproheptadine—Rash—Epirubicin—stomach cancer	0.000153	0.00096	CcSEcCtD
Cyproheptadine—Dermatitis—Epirubicin—stomach cancer	0.000153	0.000959	CcSEcCtD
Cyproheptadine—Headache—Epirubicin—stomach cancer	0.000152	0.000954	CcSEcCtD
Cyproheptadine—Dizziness—Doxorubicin—stomach cancer	0.000148	0.000932	CcSEcCtD
Cyproheptadine—Nausea—Epirubicin—stomach cancer	0.000144	0.000904	CcSEcCtD
Cyproheptadine—Vomiting—Doxorubicin—stomach cancer	0.000143	0.000896	CcSEcCtD
Cyproheptadine—Nortriptyline—ALB—stomach cancer	0.000142	0.0236	CrCbGaD
Cyproheptadine—Rash—Doxorubicin—stomach cancer	0.000142	0.000888	CcSEcCtD
Cyproheptadine—Dermatitis—Doxorubicin—stomach cancer	0.000141	0.000887	CcSEcCtD
Cyproheptadine—Headache—Doxorubicin—stomach cancer	0.000141	0.000883	CcSEcCtD
Cyproheptadine—Nausea—Doxorubicin—stomach cancer	0.000133	0.000837	CcSEcCtD
Cyproheptadine—Amitriptyline—ALB—stomach cancer	9.88e-05	0.0164	CrCbGaD
Cyproheptadine—DRD2—Signaling Pathways—IL6R—stomach cancer	8.68e-06	5.75e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—MAPK3—stomach cancer	8.65e-06	5.73e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—VEGFA—stomach cancer	8.6e-06	5.69e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IL6R—stomach cancer	8.54e-06	5.65e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IL6R—stomach cancer	8.52e-06	5.64e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—MAPK1—stomach cancer	8.52e-06	5.64e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—STAT3—stomach cancer	8.52e-06	5.64e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—EGFR—stomach cancer	8.52e-06	5.64e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MAPK8—stomach cancer	8.5e-06	5.63e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IL6R—stomach cancer	8.5e-06	5.62e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IL6R—stomach cancer	8.47e-06	5.61e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—PIK3CA—stomach cancer	8.42e-06	5.57e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IL6R—stomach cancer	8.39e-06	5.55e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—MAPK1—stomach cancer	8.38e-06	5.55e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—EGFR—stomach cancer	8.38e-06	5.55e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—PIK3CA—stomach cancer	8.38e-06	5.54e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—MAPK1—stomach cancer	8.36e-06	5.54e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—EGFR—stomach cancer	8.36e-06	5.54e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—MAPK1—stomach cancer	8.34e-06	5.52e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—EGFR—stomach cancer	8.34e-06	5.52e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—MAPK1—stomach cancer	8.31e-06	5.5e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—EGFR—stomach cancer	8.31e-06	5.5e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PTGS2—stomach cancer	8.28e-06	5.48e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—ERBB2—stomach cancer	8.27e-06	5.47e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—MAPK1—stomach cancer	8.23e-06	5.45e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—EGFR—stomach cancer	8.23e-06	5.45e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—ERBB2—stomach cancer	8.23e-06	5.44e-05	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—PIK3CA—stomach cancer	8.14e-06	5.39e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—MAPK3—stomach cancer	8.14e-06	5.39e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—SERPINE1—stomach cancer	8.13e-06	5.38e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—KRAS—stomach cancer	8.05e-06	5.33e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—PIK3CA—stomach cancer	8.01e-06	5.3e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—SERPINE1—stomach cancer	8e-06	5.29e-05	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—PIK3CA—stomach cancer	7.99e-06	5.29e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—SERPINE1—stomach cancer	7.98e-06	5.28e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—PIK3CA—stomach cancer	7.97e-06	5.27e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—SERPINE1—stomach cancer	7.96e-06	5.27e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—PIK3CA—stomach cancer	7.94e-06	5.26e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—SERPINE1—stomach cancer	7.93e-06	5.25e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—KRAS—stomach cancer	7.92e-06	5.24e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—MYC—stomach cancer	7.92e-06	5.24e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—KRAS—stomach cancer	7.9e-06	5.23e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—KRAS—stomach cancer	7.87e-06	5.21e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—PIK3CA—stomach cancer	7.86e-06	5.21e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—SERPINE1—stomach cancer	7.85e-06	5.2e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—VEGFA—stomach cancer	7.85e-06	5.2e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—KRAS—stomach cancer	7.85e-06	5.2e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—RHOA—stomach cancer	7.84e-06	5.19e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CXCL8—stomach cancer	7.84e-06	5.19e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CXCL8—stomach cancer	7.8e-06	5.16e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—HRAS—stomach cancer	7.79e-06	5.16e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—STAT3—stomach cancer	7.78e-06	5.15e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—KRAS—stomach cancer	7.77e-06	5.15e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—NOS3—stomach cancer	7.76e-06	5.14e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—HRAS—stomach cancer	7.75e-06	5.13e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—MAPK1—stomach cancer	7.74e-06	5.13e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—EGFR—stomach cancer	7.74e-06	5.12e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—RHOA—stomach cancer	7.72e-06	5.11e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—RHOA—stomach cancer	7.7e-06	5.1e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—RHOA—stomach cancer	7.67e-06	5.08e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CDKN1B—stomach cancer	7.66e-06	5.07e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—RHOA—stomach cancer	7.65e-06	5.06e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—NOS3—stomach cancer	7.64e-06	5.05e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—NOS3—stomach cancer	7.62e-06	5.04e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CDKN1B—stomach cancer	7.62e-06	5.04e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—NOS3—stomach cancer	7.6e-06	5.03e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—RHOA—stomach cancer	7.58e-06	5.01e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—NOS3—stomach cancer	7.57e-06	5.01e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—NOS3—stomach cancer	7.5e-06	4.96e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—IL6—stomach cancer	7.46e-06	4.93e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MAPK3—stomach cancer	7.43e-06	4.92e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—IL6—stomach cancer	7.42e-06	4.91e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—PIK3CA—stomach cancer	7.39e-06	4.89e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—KRAS—stomach cancer	7.31e-06	4.84e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CCND1—stomach cancer	7.3e-06	4.83e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—JUN—stomach cancer	7.29e-06	4.82e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—PIK3CA—stomach cancer	7.27e-06	4.81e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CCND1—stomach cancer	7.27e-06	4.81e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—ERBB2—stomach cancer	7.26e-06	4.8e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—PIK3CA—stomach cancer	7.26e-06	4.8e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—JUN—stomach cancer	7.25e-06	4.8e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—PIK3CA—stomach cancer	7.23e-06	4.79e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MYC—stomach cancer	7.22e-06	4.78e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—PIK3CA—stomach cancer	7.21e-06	4.77e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—ERBB2—stomach cancer	7.14e-06	4.73e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—PIK3CA—stomach cancer	7.14e-06	4.73e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—ERBB2—stomach cancer	7.13e-06	4.72e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—ERBB2—stomach cancer	7.1e-06	4.7e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MMP9—stomach cancer	7.09e-06	4.69e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—ERBB2—stomach cancer	7.08e-06	4.69e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MAPK1—stomach cancer	7.07e-06	4.68e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—EGFR—stomach cancer	7.07e-06	4.68e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CDKN1A—stomach cancer	7.07e-06	4.68e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MMP9—stomach cancer	7.06e-06	4.67e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CDKN1A—stomach cancer	7.03e-06	4.65e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—ERBB2—stomach cancer	7.01e-06	4.64e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MAPK8—stomach cancer	6.9e-06	4.56e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CXCL8—stomach cancer	6.88e-06	4.56e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MAPK8—stomach cancer	6.86e-06	4.54e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—HRAS—stomach cancer	6.84e-06	4.53e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CXCL8—stomach cancer	6.77e-06	4.48e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CXCL8—stomach cancer	6.76e-06	4.47e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CXCL8—stomach cancer	6.74e-06	4.46e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—HRAS—stomach cancer	6.73e-06	4.45e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CDKN1B—stomach cancer	6.72e-06	4.45e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—PIK3CA—stomach cancer	6.72e-06	4.45e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CXCL8—stomach cancer	6.72e-06	4.45e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—HRAS—stomach cancer	6.72e-06	4.44e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—HRAS—stomach cancer	6.69e-06	4.43e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—KRAS—stomach cancer	6.68e-06	4.42e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—HRAS—stomach cancer	6.67e-06	4.42e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CXCL8—stomach cancer	6.65e-06	4.4e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CDKN1B—stomach cancer	6.61e-06	4.38e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—HRAS—stomach cancer	6.61e-06	4.37e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CDKN1B—stomach cancer	6.6e-06	4.37e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CDKN1B—stomach cancer	6.58e-06	4.35e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CDKN1B—stomach cancer	6.56e-06	4.34e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—IL6—stomach cancer	6.55e-06	4.33e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—TP53—stomach cancer	6.5e-06	4.3e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CDKN1B—stomach cancer	6.49e-06	4.3e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—IL6—stomach cancer	6.44e-06	4.26e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—IL6—stomach cancer	6.43e-06	4.25e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CCND1—stomach cancer	6.41e-06	4.24e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—IL6—stomach cancer	6.41e-06	4.24e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—JUN—stomach cancer	6.4e-06	4.24e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—IL6—stomach cancer	6.39e-06	4.23e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—VEGFA—stomach cancer	6.37e-06	4.21e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—VEGFA—stomach cancer	6.34e-06	4.19e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—IL6—stomach cancer	6.32e-06	4.19e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CCND1—stomach cancer	6.31e-06	4.18e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—STAT3—stomach cancer	6.31e-06	4.17e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—JUN—stomach cancer	6.3e-06	4.17e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CCND1—stomach cancer	6.3e-06	4.17e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—JUN—stomach cancer	6.28e-06	4.16e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CCND1—stomach cancer	6.28e-06	4.15e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—STAT3—stomach cancer	6.27e-06	4.15e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—JUN—stomach cancer	6.26e-06	4.15e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CCND1—stomach cancer	6.26e-06	4.14e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—JUN—stomach cancer	6.24e-06	4.13e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MMP9—stomach cancer	6.23e-06	4.12e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—HRAS—stomach cancer	6.22e-06	4.11e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CDKN1A—stomach cancer	6.2e-06	4.11e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CCND1—stomach cancer	6.2e-06	4.1e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—JUN—stomach cancer	6.18e-06	4.09e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—PIK3CA—stomach cancer	6.13e-06	4.06e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MMP9—stomach cancer	6.13e-06	4.06e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MMP9—stomach cancer	6.11e-06	4.05e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CDKN1A—stomach cancer	6.1e-06	4.04e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MMP9—stomach cancer	6.09e-06	4.03e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CDKN1A—stomach cancer	6.09e-06	4.03e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MMP9—stomach cancer	6.07e-06	4.02e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CDKN1A—stomach cancer	6.07e-06	4.02e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MAPK8—stomach cancer	6.06e-06	4.01e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CDKN1A—stomach cancer	6.05e-06	4.01e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MAPK3—stomach cancer	6.02e-06	3.99e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MMP9—stomach cancer	6.02e-06	3.98e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CDKN1A—stomach cancer	5.99e-06	3.97e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MAPK3—stomach cancer	5.99e-06	3.97e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MAPK8—stomach cancer	5.96e-06	3.94e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—IL6—stomach cancer	5.95e-06	3.94e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MAPK8—stomach cancer	5.95e-06	3.94e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—TP53—stomach cancer	5.93e-06	3.93e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MAPK8—stomach cancer	5.93e-06	3.92e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MAPK8—stomach cancer	5.91e-06	3.91e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MYC—stomach cancer	5.86e-06	3.88e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MAPK8—stomach cancer	5.85e-06	3.87e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MYC—stomach cancer	5.83e-06	3.86e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MAPK1—stomach cancer	5.73e-06	3.79e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—EGFR—stomach cancer	5.73e-06	3.79e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MAPK1—stomach cancer	5.7e-06	3.77e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—EGFR—stomach cancer	5.7e-06	3.77e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—HRAS—stomach cancer	5.67e-06	3.76e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—VEGFA—stomach cancer	5.59e-06	3.7e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—STAT3—stomach cancer	5.54e-06	3.66e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—VEGFA—stomach cancer	5.5e-06	3.64e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—VEGFA—stomach cancer	5.49e-06	3.63e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—VEGFA—stomach cancer	5.47e-06	3.62e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—VEGFA—stomach cancer	5.45e-06	3.61e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—STAT3—stomach cancer	5.45e-06	3.61e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—STAT3—stomach cancer	5.44e-06	3.6e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—IL6—stomach cancer	5.43e-06	3.59e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—STAT3—stomach cancer	5.42e-06	3.59e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—KRAS—stomach cancer	5.41e-06	3.58e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—VEGFA—stomach cancer	5.4e-06	3.58e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—STAT3—stomach cancer	5.4e-06	3.57e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—KRAS—stomach cancer	5.39e-06	3.56e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—STAT3—stomach cancer	5.35e-06	3.54e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MAPK3—stomach cancer	5.29e-06	3.5e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MAPK3—stomach cancer	5.2e-06	3.44e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MAPK3—stomach cancer	5.19e-06	3.44e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MAPK3—stomach cancer	5.18e-06	3.43e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MAPK3—stomach cancer	5.16e-06	3.42e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MYC—stomach cancer	5.14e-06	3.4e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MAPK3—stomach cancer	5.11e-06	3.38e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PIK3CA—stomach cancer	5.09e-06	3.37e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MYC—stomach cancer	5.06e-06	3.35e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MYC—stomach cancer	5.05e-06	3.34e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MYC—stomach cancer	5.03e-06	3.33e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MAPK1—stomach cancer	5.03e-06	3.33e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—EGFR—stomach cancer	5.03e-06	3.33e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MYC—stomach cancer	5.02e-06	3.32e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—PIK3CA—stomach cancer	4.97e-06	3.29e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MYC—stomach cancer	4.97e-06	3.29e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MAPK1—stomach cancer	4.95e-06	3.28e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—EGFR—stomach cancer	4.95e-06	3.28e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PIK3CA—stomach cancer	4.95e-06	3.28e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MAPK1—stomach cancer	4.94e-06	3.27e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—EGFR—stomach cancer	4.94e-06	3.27e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MAPK1—stomach cancer	4.93e-06	3.26e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—EGFR—stomach cancer	4.92e-06	3.26e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MAPK1—stomach cancer	4.91e-06	3.25e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—EGFR—stomach cancer	4.91e-06	3.25e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MAPK1—stomach cancer	4.86e-06	3.22e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—EGFR—stomach cancer	4.86e-06	3.22e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—TP53—stomach cancer	4.81e-06	3.18e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—TP53—stomach cancer	4.79e-06	3.17e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—KRAS—stomach cancer	4.75e-06	3.15e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—KRAS—stomach cancer	4.68e-06	3.1e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—KRAS—stomach cancer	4.67e-06	3.09e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—KRAS—stomach cancer	4.65e-06	3.08e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—KRAS—stomach cancer	4.64e-06	3.07e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—HRAS—stomach cancer	4.6e-06	3.05e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—KRAS—stomach cancer	4.59e-06	3.04e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—HRAS—stomach cancer	4.58e-06	3.03e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IL6—stomach cancer	4.4e-06	2.92e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IL6—stomach cancer	4.38e-06	2.9e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PIK3CA—stomach cancer	4.37e-06	2.89e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PIK3CA—stomach cancer	4.3e-06	2.84e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PIK3CA—stomach cancer	4.29e-06	2.84e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PIK3CA—stomach cancer	4.27e-06	2.83e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PIK3CA—stomach cancer	4.26e-06	2.82e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TP53—stomach cancer	4.22e-06	2.8e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PIK3CA—stomach cancer	4.22e-06	2.79e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TP53—stomach cancer	4.16e-06	2.75e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TP53—stomach cancer	4.15e-06	2.75e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TP53—stomach cancer	4.13e-06	2.74e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TP53—stomach cancer	4.12e-06	2.73e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TP53—stomach cancer	4.08e-06	2.7e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—HRAS—stomach cancer	4.04e-06	2.67e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—HRAS—stomach cancer	3.98e-06	2.63e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—HRAS—stomach cancer	3.97e-06	2.63e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—HRAS—stomach cancer	3.95e-06	2.62e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—HRAS—stomach cancer	3.94e-06	2.61e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—HRAS—stomach cancer	3.9e-06	2.58e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IL6—stomach cancer	3.87e-06	2.56e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IL6—stomach cancer	3.8e-06	2.52e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IL6—stomach cancer	3.8e-06	2.51e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IL6—stomach cancer	3.78e-06	2.5e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IL6—stomach cancer	3.77e-06	2.5e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IL6—stomach cancer	3.74e-06	2.47e-05	CbGpPWpGaD
